Cai He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Cai He has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bo Liu
Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China
1 shared publication - Jingwei Guo
Department of Pathology, Shengjing Hospital of China Medical University, Shenyang 110004, China
1 shared publication - Peng Su
Medical Research Center, Shengjing Hospital of China Medical University , 36 Sanhao Street, Heping District, Shenyang City 110004, Liaoning Province , China
1 shared publication - Xiangchen Hu
Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China
1 shared publication - Youwei Kou
Shengjing Hospital of China Medical University
1 shared publication - Zhe Wang
Department of Pathology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang City, Liaoning Province, 110004, China.
1 shared publication
Latest Publications
- Open Access
- 4 September 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13640
Characterization of a Human Gastrointestinal Stromal Tumor Cell Line Established by SV40LT-Mediated Immortalization
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the digestive tract and originate from the interstitial cells of Cajal (ICC), which is the pacemaker for peristaltic movement in the gastrointestinal tract. Existing GIST cell lines are widely used as cell models for in vitro experimental studies because the mutation sites are known. However, the immortalization methods of these cell lines are unknown, and no Chinese patient-derived GIST cell lines have been documented. Here, we transfected simian virus 40 large T antigen (SV40LT) into primary GIST cells to establish an immortalized human GIST cell line (ImGIST) for the first time. The ImGIST cells had neuronal cell-like irregular radioactive growth and retained the fusion growth characteristics of GIST cells. They stably expressed signature proteins, maintained the biological and genomic characteristics of normal primary GIST cells, and responded well to imatinib, suggesting that ImGIST could be a potential in vitro model for research in GIST to explore the molecular pathogenesis, drug resistance mechanisms, and the development of new adjuvant therapeutic options.
- 4 September 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13640
Open AccessCharacterization of a Human Gastrointestinal Stromal Tumor Cell Line Established by SV40LT-Mediated Immortalization
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the digestive tract and originate from the interstitial cells of Cajal (ICC), which is the pacemaker for peristaltic movement in the gastrointestinal tract. Existing GIST cell lines are widely used as cell models for in vitro experimental studies because the mutation sites are known. However, the immortalization methods of these cell lines are unknown, and no Chinese patient-derived GIST cell lines have been documented. Here, we transfected simian virus 40 large T antigen (SV40LT) into primary GIST cells to establish an immortalized human GIST cell line (ImGIST) for the first time. The ImGIST cells had neuronal cell-like irregular radioactive growth and retained the fusion growth characteristics of GIST cells. They stably expressed signature proteins, maintained the biological and genomic characteristics of normal primary GIST cells, and responded well to imatinib, suggesting that ImGIST could be a potential in vitro model for research in GIST to explore the molecular pathogenesis, drug resistance mechanisms, and the development of new adjuvant therapeutic options.